$0.6682
-0.0063-0.93%
最終更新: Sep 30, 5:56 PM
$0.6502
-0.0243-3.6%
Benzinga
Benzinga
Benzinga
木曜日, 10 01
Benzinga
© 2026 Benzinga | All Rights Reserved
Oncolytics Biotech (ONCY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.07 | $-0.07 | $-0.07 | $-0.06 |
| Actual | $-0.08 | $-0.06 | $-0.09 | $-0.10 |
| Surprise | -14.3% | +14.3% | -28.6% | -66.7% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.07 | $-0.08 | $-0.04 | $-0.05 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.08 | $-0.07 | -14.3 % |
| Q1 | May 14, 2026 | $-0.06 | $-0.07 | 14.3 % |
| Q4 | Mar 30, 2026 | $-0.09 | $-0.07 | -28.6 % |
| Q3 | Nov 12, 2025 | $-0.10 | $-0.06 | -66.7 % |